Member access

4-Traders Homepage  >  Shares  >  London Stock Exchange  >  GlaxoSmithKline plc    GSK   GB0009252882

GLAXOSMITHKLINE PLC (GSK)

144
SummaryQuotesChart AnalysisNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
News SummaryMost relevantAll news 

GlaxoSmithKline: European Commission Authorizes Nimenix

04/27/2012 | 08:24am US/Eastern
Recommend:
0

GlaxoSmithKline PLC (>> GlaxoSmithKline plc), the drug company, said Friday that the European Commission has granted marketing authorization for Nimenrix, Meningococcal group A, C, W-135 and Y conjugate vaccine, for active immunization against invasive meningococcal disease caused by Neisseria meningitidis serogroups A, C, W-135 and Y.

-Shares at 1207 GMT, up a penny, or 0.04%, at 1,420.5 pence valuing the company at GBP71.61 billion.

-By Rory Gallivan, Dow Jones Newswires; 44-20-7842-9411; rory.gallivan@dowjones.com

Stocks mentioned in the article : GlaxoSmithKline plc
Recommend :
0
React to this article
Latest news on GLAXOSMITHKLINE PLC
6h ago Isis Pharma Earns USD1.5 Million From Glaxo For ISIS-GSK4 Rx
8h agoDJMARKET SNAPSHOT : U.S. Stocks: Futures Flatten Ahead Of ADP Employment, ISM
12h ago Plant-based vaccines challenge big pharma for $3 billion flu market
1d ago GLAXOSMITHKLINE : GSK commits further funding to advance bioelectronics research..
1d ago GLAXOSMITHKLINE : Glaxo Announces USD5M Fund For Bioelectronics Research
2d ago GLAXOSMITHKLINE : Pub quiz
2d ago GLAXOSMITHKLINE : GSK announces overall survival results from phase III BREAK-3 ..
2d ago GLAXOSMITHKLINE : Glaxo Phase III Tafinlar Study Shows Survival Rate Of 45% At T..
2d ago REN CAP : Analysts Raise GlaxoSmithKline's Expected TP to N76
5d ago GLAXOSMITHKLINE : Banking: RBS chairman Hampton off to GlaxoSmithKline
Advertisement
Chart
Duration : Period :
GlaxoSmithKline plc Technical Analysis Chart | GSK | GB0009252882 | 4-Traders
Income Statement Evolution
More Financials
Dynamic quotes  
ON
| OFF